A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis | MicrobiomeTrials← Back to trialsNCT07302360
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-12-11Est. Completion: 2028-06-30
Enrollment target: 200 participants Locations- Peking Union Medical College Hospital, Beijing, China
- Peking University People's Hospital, Beijing, China
- Changzhou No 2 Peoples Hospital, Changzhou, China
- The First Affiliated Hospital Sun Yat-Sen University, Guangzhou, China
- The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
- The Second Affiliated Hospital of Zhejiang University, Hangzhou, China
- Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing, China
- The Second Hospital of Hebei Medical University, Shijiazhuang, China
- Tianjin Medical University General Hospital, Tianjin, China
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Recruiting
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that requires regular monitoring of disease activity. Cu…
Asyut, EgyptEst. completion Jan 31, 2027